These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7833150)

  • 21. Tamoxifen and secondary tumours. An update.
    Wilking N; Isaksson E; von Schoultz E
    Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis of tamoxifen-associated endometrial cancer.
    Lasset C; Mignotte H; Bonadona V; Chauvin F
    J Clin Oncol; 1998 Jul; 16(7):2573. PubMed ID: 9667283
    [No Abstract]   [Full Text] [Related]  

  • 23. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis.
    Assikis VJ; Neven P; Jordan VC; Vergote I
    Eur J Cancer; 1996 Aug; 32A(9):1464-76. PubMed ID: 8911103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of tamoxifen on the female genital tract.
    Senkus-Konefka E; Konefka T; Jassem J
    Cancer Treat Rev; 2004 May; 30(3):291-301. PubMed ID: 15059652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic carcinoma of the endometrium in a patient on adjunctive tamoxifen therapy for carcinoma of the breast.
    O'Neill E; Rodríguez Mojica W
    Bol Asoc Med P R; 1992 Feb; 84(2):74-7. PubMed ID: 1388459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer and duration of tamoxifen.
    Prescrire Int; 2015 Sep; 24(163):220. PubMed ID: 26417636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
    Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
    Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen experimental carcinogenicity studies: implications for human effects.
    Williams GM
    Proc Soc Exp Biol Med; 1995 Feb; 208(2):141-3. PubMed ID: 7831345
    [No Abstract]   [Full Text] [Related]  

  • 29. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
    Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endolymphatic stromal myosis associated with tamoxifen use.
    Eddy GL; Mazur MT
    Gynecol Oncol; 1997 Feb; 64(2):262-4. PubMed ID: 9038273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
    Magriples U; Naftolin F; Schwartz PE; Carcangiu ML
    J Clin Oncol; 1993 Mar; 11(3):485-90. PubMed ID: 8383191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gynecologic surveillance of women on tamoxifen: first do no harm.
    Runowicz CD
    J Clin Oncol; 2000 Oct; 18(20):3457-8. PubMed ID: 11032584
    [No Abstract]   [Full Text] [Related]  

  • 33. Tamoxifen and the uterus and endometrium.
    Stewart HJ; Knight GM
    Lancet; 1989 Feb; 1(8634):375-6. PubMed ID: 18446929
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term toxicity of tamoxifen.
    Rutqvist LE
    Recent Results Cancer Res; 1993; 127():257-66. PubMed ID: 8502824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.
    Greaves P; Goonetilleke R; Nunn G; Topham J; Orton T
    Cancer Res; 1993 Sep; 53(17):3919-24. PubMed ID: 8358718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer.
    Peters-Engl C; Medl M; Danmayr E; Mirau M; Alth G; Leodolter S
    Anticancer Res; 1996; 16(5B):3241-6. PubMed ID: 8920798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolism and genotoxicity of tamoxifen.
    White IN; Martin EA; Styles J; Lim CK; Carthew P; Smith LL
    Prog Clin Biol Res; 1997; 396():257-70. PubMed ID: 9108603
    [No Abstract]   [Full Text] [Related]  

  • 38. Gynecologic tumors in tamoxifen-treated women with breast cancer.
    Seoud MA; Johnson J; Weed JC
    Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.
    Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N
    Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
    Fornander T; Hellström AC; Moberger B
    J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.